225 related articles for article (PubMed ID: 27401066)
1. Distinct gene regulatory programs define the inhibitory effects of liver X receptors and PPARG on cancer cell proliferation.
Savic D; Ramaker RC; Roberts BS; Dean EC; Burwell TC; Meadows SK; Cooper SJ; Garabedian MJ; Gertz J; Myers RM
Genome Med; 2016 Jul; 8(1):74. PubMed ID: 27401066
[TBL] [Abstract][Full Text] [Related]
2. Lysosome-Dependent LXR and PPARδ Activation Upon Efferocytosis in Human Macrophages.
Mota AC; Dominguez M; Weigert A; Snodgrass RG; Namgaladze D; Brüne B
Front Immunol; 2021; 12():637778. PubMed ID: 34025647
[TBL] [Abstract][Full Text] [Related]
3. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis.
Zhou J; Febbraio M; Wada T; Zhai Y; Kuruba R; He J; Lee JH; Khadem S; Ren S; Li S; Silverstein RL; Xie W
Gastroenterology; 2008 Feb; 134(2):556-67. PubMed ID: 18242221
[TBL] [Abstract][Full Text] [Related]
4. Analysis of LXR Nuclear Receptor Cistrome Through ChIP-Seq Data Bioinformatics.
de la Rosa JV; Ramón-Vázquez A; Tabraue C; Castrillo A
Methods Mol Biol; 2019; 1951():99-109. PubMed ID: 30825147
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal negative cross-talk between liver X receptors (LXRs) and STAT1: effects on IFN-γ-induced inflammatory responses and LXR-dependent gene expression.
Pascual-García M; Rué L; León T; Julve J; Carbó JM; Matalonga J; Auer H; Celada A; Escolà-Gil JC; Steffensen KR; Pérez-Navarro E; Valledor AF
J Immunol; 2013 Jun; 190(12):6520-32. PubMed ID: 23686490
[TBL] [Abstract][Full Text] [Related]
6. Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism.
Nguyen-Vu T; Vedin LL; Liu K; Jonsson P; Lin JZ; Candelaria NR; Candelaria LP; Addanki S; Williams C; Gustafsson JÅ; Steffensen KR; Lin CY
Breast Cancer Res; 2013 Jun; 15(3):R51. PubMed ID: 23809258
[TBL] [Abstract][Full Text] [Related]
7. Genomic binding and regulation of gene expression by the thyroid carcinoma-associated PAX8-PPARG fusion protein.
Zhang Y; Yu J; Lee C; Xu B; Sartor MA; Koenig RJ
Oncotarget; 2015 Dec; 6(38):40418-32. PubMed ID: 26595524
[TBL] [Abstract][Full Text] [Related]
8. Novel Liver X Receptor Ligand GAC0001E5 Disrupts Glutamine Metabolism and Induces Oxidative Stress in Pancreatic Cancer Cells.
Srivastava S; Widmann S; Ho C; Nguyen D; Nguyen A; Premaratne A; Gustafsson JÅ; Lin CY
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348693
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of liver X receptor transcriptional activity by peroxisome-proliferator-activated receptor gamma co-activator 1 alpha.
Oberkofler H; Schraml E; Krempler F; Patsch W
Biochem J; 2003 Apr; 371(Pt 1):89-96. PubMed ID: 12470296
[TBL] [Abstract][Full Text] [Related]
10. LXRα-mediated downregulation of EGFR suppress colorectal cancer cell proliferation.
Liang X; Cao Y; Xiang S; Xiang Z
J Cell Biochem; 2019 Oct; 120(10):17391-17404. PubMed ID: 31104333
[TBL] [Abstract][Full Text] [Related]
11. Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-alpha.
Tobin KA; Steineger HH; Alberti S; Spydevold O; Auwerx J; Gustafsson JA; Nebb HI
Mol Endocrinol; 2000 May; 14(5):741-52. PubMed ID: 10809236
[TBL] [Abstract][Full Text] [Related]
12. Activation of peroxisome proliferator-activated receptor gamma is crucial for antitumoral effects of 6-iodolactone.
Nava-Villalba M; Nuñez-Anita RE; Bontempo A; Aceves C
Mol Cancer; 2015 Sep; 14():168. PubMed ID: 26376791
[TBL] [Abstract][Full Text] [Related]
13. Liver X receptors inhibit proliferation of human colorectal cancer cells and growth of intestinal tumors in mice.
Lo Sasso G; Bovenga F; Murzilli S; Salvatore L; Di Tullio G; Martelli N; D'Orazio A; Rainaldi S; Vacca M; Mangia A; Palasciano G; Moschetta A
Gastroenterology; 2013 Jun; 144(7):1497-507, 1507.e1-13. PubMed ID: 23419360
[TBL] [Abstract][Full Text] [Related]
14. High expression of liver histone deacetylase 3 contributes to high-fat-diet-induced metabolic syndrome by suppressing the PPAR-γ and LXR-α-pathways in E3 rats.
Li D; Wang X; Ren W; Ren J; Lan X; Wang F; Li H; Zhang F; Han Y; Song T; Holmdahl R; Lu S
Mol Cell Endocrinol; 2011 Sep; 344(1-2):69-80. PubMed ID: 21763752
[TBL] [Abstract][Full Text] [Related]
15. Genomic binding of PAX8-PPARG fusion protein regulates cancer-related pathways and alters the immune landscape of thyroid cancer.
Zhang Y; Yu J; Grachtchouk V; Qin T; Lumeng CN; Sartor MA; Koenig RJ
Oncotarget; 2017 Jan; 8(4):5761-5773. PubMed ID: 28008156
[TBL] [Abstract][Full Text] [Related]
16. Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liver.
Anderson SP; Dunn C; Laughter A; Yoon L; Swanson C; Stulnig TM; Steffensen KR; Chandraratna RA; Gustafsson JA; Corton JC
Mol Pharmacol; 2004 Dec; 66(6):1440-52. PubMed ID: 15371561
[TBL] [Abstract][Full Text] [Related]
17. UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression.
Sabatino L; Fucci A; Pancione M; Carafa V; Nebbioso A; Pistore C; Babbio F; Votino C; Laudanna C; Ceccarelli M; Altucci L; Bonapace IM; Colantuoni V
Oncogene; 2012 Dec; 31(49):5061-72. PubMed ID: 22286757
[TBL] [Abstract][Full Text] [Related]
18. The peroxisome proliferator-activated receptor gamma regulates trophoblast cell differentiation in mink (Mustela vison).
Desmarais JA; Lopes FL; Zhang H; Das SK; Murphy BD
Biol Reprod; 2007 Nov; 77(5):829-39. PubMed ID: 17615406
[TBL] [Abstract][Full Text] [Related]
19. The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology.
Kiss M; Czimmerer Z; Nagy L
J Allergy Clin Immunol; 2013 Aug; 132(2):264-86. PubMed ID: 23905916
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator activator receptor gamma (PPARG) regulates conceptus elongation in sheep.
Brooks KE; Burns GW; Spencer TE
Biol Reprod; 2015 Feb; 92(2):42. PubMed ID: 25519185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
